Recent news
Finalization of shareholder change
Partners Group and PSP Investments have finalized the acquisition of Cerba HealthCare, a leading European operator of clinical pathology laboratories, from PAI Partners.
PR_Closing_Cerba_Healthcare_EN.pdfCerba HealthCare Press Release
Paris, France, March 21, 2017. Cerba Healthcare S.A.S. and its affiliates (the “Cerba Group”) announced today that NewCo Sab MidCo S.A.S...
Cerba-HealthCare-Press-Release.pdfCerba HealthCare - Launch Press Release
Cerba HealthCare - Launch Press Release
Cerba_HealthCare_Launch__Press_Release.pdfLicensing agreement between Cerba and IntegraGen for the commercialization...
Licensing agreement between Cerba and IntegraGen for the commercialization of miR-31-3p tumor expression test in cancerology.
Cerba_IntegraGen_Press_Release_EN.pdfCerba HealthCare S.A.S announces preliminary financial results ...
Cerba HealthCare S.A.S announces preliminary financial results for year end 2016 and expected redemption of existing notes.
Press_Release_2016.pdfiDTECT™ BLOOD test for precision diagnosis of infectious diseases
Diagnosis of infectious diseasesthe iDTECT™ BLOOD test available for clinical use in the precision Laboratoire CERBA and PATHOQUEST announce partnership making.
Cerba_PATHOQUEST_PR_EN.pdfCerba HealthCare strengthens its positions in Europe
Cerba HealthCare is announcing the acquisition of DELTAMEDICA, a medical group located in Northern Italy in the Milan region.
CERBA HEALTHCARE_DELTAMEDICA_EN.pdf